4 Podcast Episodes
Kazia Therapeutics’ (ASX: KZA) oncology drug paxalisib continues to generate positive trial data (w/ James Garner)
Kazia Therapeutics’ (ASX: KZA) oncology drug paxalisib continues to generate positive trial data (w/ James Garner)
Kazia Therapeutics (ASX: KZA) CEO James Garner joins Small Caps to discuss the company’s ongoing development of its lead... Read more
9 Aug 2022
•
22mins
Kazia tackles the curse of US politicians with its innovative drug candidate
Kazia tackles the curse of US politicians with its innovative drug candidate
In this episode Tim chats with James Garner, CEO at Kazia Therapeutics (ASX:KZA).
12 Mar 2021
•
23mins
Dr James Garner - Kazia Therapeutics - A novel approach to novel drug development
Dr James Garner - Kazia Therapeutics - A novel approach to novel drug development
Dr James Garner is the CEO of Kazia Therapeutics, an oncology-focused biotechnology company developing innovative anti-c... Read more
22 Jun 2020
•
22mins
Kazia Therapeutics: Beating glioblastoma, crossing the blood-brain barrier and the joys of receiving a gong from Jacinda Ardern.
Kazia Therapeutics: Beating glioblastoma, crossing the blood-brain barrier and the joys of receiving a gong from Jacinda Ardern.
Tim chats with Dr James Garner, CEO & Executive Director of Kazia Therapeutics (ASX:KZA).
9 Oct 2019
•
20mins